Garden State Cancer Center at the Center for Molecular Medicine and Immunology

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Garden State Cancer Center at the Center for Molecular Medicine and Immunology sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials none currently recruiting 6 completed early-phase tilt upper quartile by trial count

Garden State Cancer Center at the Center for Molecular Medicine and Immunology: 6 sponsored US clinical trials, none currently recruiting.

Garden State Cancer Center at the Center for Molecular Medicine and Immunology sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Head and Neck Cancer, with 1 trials.

Upper-quartile sponsor footprint

Garden State Cancer Center at the Center for Molecular Medicine and Immunology sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

6 total, page 1 of 1

COMPLETED Phase 1

Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer

NCT00004177
COMPLETED Phase 1

Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer

NCT00004048
COMPLETED Phase 1

Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

NCT00004085
COMPLETED Phase 1

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

NCT00004084
COMPLETED Phase 1

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia

NCT00004107
COMPLETED Phase 1

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer

NCT00004087

Phase Distribution

PhaseTrial count
Phase 1 6

Therapeutic Areas

Head and Neck Cancer 1

How the Garden State Cancer Center at the Center for Molecular Medicine and Immunology early-phase archive is shaped

6 indexed studies, none listed as recruiting (0% open); 6 completed (100%).

Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).

Top condition: Head and Neck Cancer (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Garden State Cancer Center at the Center for Molecular Medicine and Immunology: archived-pipeline peers nationwide

Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Garden State Cancer Center at the Center for Molecular Medicine and Immunology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60%80% Total trials Recruiting share Garden State Cancer Center at the Center for Molecular Medicine and Immunology23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan Branch10xBio22nd Century Group3-C Institute for Social Development3 Waves Wellness
Garden State Cancer Center at the Center for Molecular Medicine and Immunology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Garden State Cancer Center at the Center for Molecular Medicine and Immunology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Garden State Cancer Center at the Center for Molecular Medicine and Immunology page

6 registered trials is a research-attention snapshot, not an endorsement of Garden State Cancer Center at the Center for Molecular Medicine and Immunology or any single study.

  • None of Garden State Cancer Center at the Center for Molecular Medicine and Immunology's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Head and Neck Cancer is the condition Garden State Cancer Center at the Center for Molecular Medicine and Immunology studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Head and Neck Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Garden State Cancer Center at the Center for Molecular Medicine and Immunology pipeline card: 6 registered trials from official public datasets.Report a data error.